Company page
Neurosense Therapeutics Ltd.
Neurosense Therapeutics Ltd. is a public company traded under the ticker NRSN in the American market. With a market capitalization of approximately $28.4 million, the company focuses on developing innovative therapies for neurodegenerative diseases. Its research aims to address significant unmet medical needs in this area.
- Ticker
- NRSN:NASDAQ
- Asset type
- Stock
- Market cap
- $28.4M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD